Differential diagnosis of inflammatory bowel disease: imitations and complications

被引:93
作者
Gecse, Krisztina B. [1 ]
Vermeire, Severine [2 ]
机构
[1] Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[2] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, B-3000 Leuven, Belgium
来源
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2018年 / 3卷 / 09期
关键词
EVIDENCE-BASED CONSENSUS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; FISTULIZING CROHNS-DISEASE; 5TH SCIENTIFIC WORKSHOP; INTESTINAL TUBERCULOSIS; COLITIS; MANAGEMENT; THERAPY; HISTOPLASMOSIS; PATHOGENESIS;
D O I
10.1016/S2468-1253(18)30159-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Inflammatory bowel disease (IBD) is characterised by episodes of relapse and periods of remission. However, the clinical features, such as abdominal pain, diarrhoea, and rectal bleeding, are not specific. Therefore, the differential diagnosis can include a broad spectrum of inflammatory or infectious diseases that mimic IBD, as well as others that might complicate existing IBD. In this Review, we provide an overview of ileocolitis of diverse causes that are relevant in the differential diagnosis of IBD. We highlight the importance of accurate patient profiling and give a practical approach to identifying factors that should trigger the search for a specific cause of intestinal inflammation. Mimics of IBD include not only infectious causes of colitis- and particular attention is required for patients from endemic areas of tuberculosis-but also vascular diseases, diversion colitis, diverticula or radiation-related injuries, drug-induced inflammation, and monogenic diseases in very-early-onset refractory disease. A superinfection with cytomegalovirus or Clostridium difficile can aggravate intestinal inflammation in IBD, especially in patients who are immunocompromised. Special consideration should be made to the differential diagnosis of perianal disease.
引用
收藏
页码:644 / 653
页数:10
相关论文
共 82 条
  • [1] The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future
    Allegretti, Jessica
    Eysenbach, Lindsay M.
    El-Nachef, Najwa
    Fischer, Monika
    Kelly, Colleen
    Kassam, Zain
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 (10) : 1710 - 1717
  • [2] Differentiating Intestinal Tuberculosis From Crohn's Disease: A Diagnostic Challenge
    Almadi, Majid Abdulrahman
    Ghosh, Subrata
    Aljebreen, Abdulrahman Mohamed
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (04) : 1003 - 1012
  • [3] Temporal Trends in Disease Outcomes Related to Clostridium Difficile Infection in Patients with Inflammatory Bowel Disease
    Ananthakrishnan, Ashwin N.
    McGinley, Emily L.
    Saeian, Kia
    Binion, David G.
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 (04) : 976 - 983
  • [4] European evidence based consensus for endoscopy in inflammatory bowel disease
    Annese, Vito
    Daperno, Marco
    Rutter, Matthew D.
    Amiot, Aurelien
    Bossuyt, Peter
    East, James
    Ferrante, Marc
    Goetz, Martin
    Katsanos, Konstantinos H.
    Kiesslich, Ralf
    Ordas, Ingrid
    Repici, Alessandro
    Rosa, Bruno
    Sebastian, Shaji
    Kucharzik, Torsten
    Eliakim, Rami
    [J]. JOURNAL OF CROHNS & COLITIS, 2013, 7 (12) : 982 - 1018
  • [5] Systemic histoplasmosis - A 15-year retrospective institutional review of 111 patients
    Assi, Maha A.
    Sandid, Mohamad S.
    Baddour, Larry M.
    Roberts, Glenn D.
    Walker, Randall C.
    [J]. MEDICINE, 2007, 86 (03) : 162 - 169
  • [6] Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4
    Beck, Kimberly E.
    Blansfield, Joseph A.
    Tran, Khoi Q.
    Feldman, Andrew L.
    Hughes, Marybeth S.
    Royal, Richard E.
    Kammula, Udai S.
    Topalian, Suzanne L.
    Sherry, Richard M.
    Kleiner, David
    Quezado, Martha
    Lowy, Israel
    Yellin, Michael
    Rosenberg, Steven A.
    Yang, James C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2283 - 2289
  • [7] Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection
    Ben-Horin, Shomron
    MargalitH, Maya
    Bossuyt, Peter
    Maul, Jochen
    Shapira, Yami
    Bojic, Daniela
    Chermesh, Irit
    Al-Rifai, Ahmad
    Schoepfer, Alain
    Bosani, Matteo
    Allez, Matthieu
    Lakatos, Peter Laszlo
    Bossa, Fabrizio
    Eser, Alexander
    Stefanelli, Tommaso
    Carbonnel, Franck
    Katsanos, Konstantinos
    Checchin, Davide
    Saenz de Miera, Ines
    Reinisch, Walter
    Chowers, Yehuda
    Moran, Gordon William
    [J]. JOURNAL OF CROHNS & COLITIS, 2010, 4 (02) : 194 - 198
  • [8] Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
    Bergqvist, Viktoria
    Hertervig, Erik
    Gedeon, Peter
    Kopljar, Marija
    Griph, Hakan
    Kinhult, Sara
    Carneiro, Ana
    Marsal, Jan
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (05) : 581 - 592
  • [9] SIDE-EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON THE SMALL AND LARGE-INTESTINE IN HUMANS
    BJARNASON, I
    HAYLLAR, J
    MACPHERSON, AJ
    RUSSELL, AS
    [J]. GASTROENTEROLOGY, 1993, 104 (06) : 1832 - 1847
  • [10] Inflammatory Skin and Bowel Disease Linked to ADAM17 Deletion
    Blaydon, Diana C.
    Biancheri, Paolo
    Di, Wei-Li
    Plagnol, Vincent
    Cabral, Rita M.
    Brooke, Matthew A.
    van Heel, David A.
    Ruschendorf, Franz
    Toynbee, Mark
    Walne, Amanda
    O'Toole, Edel A.
    Martin, Joanne E.
    Lindley, Keith
    Vulliamy, Tom
    Abrams, Dominic J.
    MacDonald, Thomas T.
    Harper, John I.
    Kelsell, David P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (16) : 1502 - 1508